Netherlands, Dec. 6 -- Project Id: 77608
Description: Grant agreement ID: 843615
Status
Ongoing project
Start date
1 May 2019
End date
30 April 2021
Funded under:
H2020-EU.1.3.2.
Overall budget:
€ 187 572,48
EU contribution
€ 187 572,48
Objective
Current medical tests for antithrombin deficiency generally measure the overall activity, being blind for the actual proteoforms of AT that contribute to the test. To ensure accurate test results, a traceability chain needs to be in place, which requires the accurate definition of the exact analyte to be measured. I hypothesize that an in-depth understanding of the pathological molecular proteoforms of antithrombin (AT) will allow for the identification of clinically rele...